AI assistant
Ganesh Benzoplast Ltd. — Capital/Financing Update 2023
Nov 7, 2023
61206_rns_2023-11-07_f710e0f8-8cb5-4d01-9b6a-9c8c56355aa7.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer
==> picture [596 x 137] intentionally omitted <==
Date: November 07, 2023
To
| The General Manager, Department of Corporate Services – Corporate Relations Department, BSE Limited, Pheeroze Jeejeebhoy Towers, Dalal Street, Fort, Mumbai – 400 001. Scrip ID: 500153 |
The Manager, Listing Department National Stock Exchange of India Limited Exchange Plaza, 5th Floor, Plot No. C/1, G-Block, Bandra Kurla Complex, Bandra (E), Mumbai – 400051 Scrip ID: GANESHBE |
|---|---|
Dear Sir/ Madam,
Sub: Statement of deviation(s) or variation(s) under Regulation 32 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No. CIR/CFD/CMD1/162/2019 dated December 24, 2019
Pursuant to the Regulation 32(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 please note that there is no deviation/ variation in the utilization of proceeds as mentioned in the objects stated in the Preferential Issue of Warrants convertible into Equity Shares.
In terms of SEBI Circular No. CIR/CFD/CMD1/162/2019 dated December 24, 2019, enclosed find herewith the Statement of NIL deviation(s) or variation(s) for the quarter ended September 30, 2023.
We request you to kindly take the above information on your record.
Thanking you, Yours Faithfully, For Ganesh Benzoplast Ltd.
Digitally signed by EKTA EKTA DHANDA DHANDA Date: 2023.11.07 15:14:41 +05'30'
Ekta Dhanda
Company Secretary & Compliance Officer
Encl: As Above
==> picture [452 x 10] intentionally omitted <==
| Statement of Deviation/ Variation In utilisation of funds raised | Statement of Deviation/ Variation In utilisation of funds raised | Statement of Deviation/ Variation In utilisation of funds raised | Statement of Deviation/ Variation In utilisation of funds raised | Statement of Deviation/ Variation In utilisation of funds raised | Statement of Deviation/ Variation In utilisation of funds raised | |
|---|---|---|---|---|---|---|
| Name of listed entity | GANESH BENZOPLAST LIMITED | |||||
| Mode of Fund Raising | Preferential Issue of Warrants Convertible into Equity Shares* | |||||
| Date of Raising Funds | 27-07-2023 | |||||
| Amount Raised | Rupees 30.13 crores | |||||
| Report filed for Quarter ended | September 30, 2023 | |||||
| Monitoring Agency | Not Applicable | |||||
| Monitoring Agency Name, if applicable | Not Applicable | |||||
| Is there a Deviation / Variation in use of funds raised | No | |||||
| If yes, whether the same is pursuant to change in terms of a contract or objects, which was approved by the shareholders |
Not Applicable | |||||
| If Yes, Date of shareholder Approval | Not Applicable | |||||
| Explanation for the Deviation / Variation | Not Applicable | |||||
| Comments of the Audit Committee after review | N | IL | ||||
| Comments of the auditors,if any | N | IL | ||||
| Objects for which funds have been raised and where there has been a deviation, in the following table |
||||||
| Original Object | Modified Object, if any |
Original Allocation |
Modified allocation, if any |
Funds Utilised as on 30.09.2023 |
Amount of deviation/ Variation for the quarter according to applicable ~~object~~ |
Remarks if any |
| Expansion and General business requirements | Not Applicable | Rs. 30.13 crores |
Not Applicable |
Rs. 30.13 crores |
Not Applicble | |
| (a) Deviation in the objects or purposes for which the funds have be (b) Deviation in the amount of funds actually utilized as against wha (c) Change in terms of a contract referred to in the fund raising docu Deviation or variation could mean: |
en raised or t was originally discl ment i.e. prospectu |
osed or s, letter of offer, |
etc. |
*Note: The Company Issued 60,00,000 equity warrants convertible into equal number of equity share at a price of Rs. 103/- each on preferential basis to the 34 investors belongs to nonpromoter group on March, 17, 2022 and On 27th july, 2023, 10 warrant holders exercised the option and the Company allotted 29,25,000(Twenty Nine Lacs Twenty Five Thousand only) Equity Shares of the face value of Rs. 1/- each at an issue price of Rs. 103/- (including a premium of Rs. 102/- per share), fully paid for 29,25,000 warrants held by them.
EKTA Digitally signed by EKTA DHANDA DHANDA Date: 2023.11.07 15:15:14 +05'30'